These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36430769)

  • 1. Integrating Network Pharmacology and Transcriptomic Strategies to Explore the Pharmacological Mechanism of Hydroxysafflor Yellow A in Delaying Liver Aging.
    Kong J; Sun S; Min F; Hu X; Zhang Y; Cheng Y; Li H; Wang X; Liu X
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating hydroxysafflor yellow A's multi-target mechanisms against alcoholic liver disease through integrative pharmacology.
    Yu HC; Bai QR; Guo JJ; Chen MY; Wang L; Tong FC; Zhang SL; Wu J
    Phytomedicine; 2024 Nov; 134():155956. PubMed ID: 39216301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic analysis of the mechanism of hydroxysafflor yellow A for treating ischemic stroke based on network pharmacology technology.
    Cui Q; Ma YH; Yu HY; Zhang YL; Qin XD; Ge SQ; Zhang GW
    Eur J Pharmacol; 2021 Oct; 908():174360. PubMed ID: 34302817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated metabolomics and network pharmacology to reveal the mechanisms of hydroxysafflor yellow A against acute traumatic brain injury.
    Li T; Zhang W; Hu E; Sun Z; Li P; Yu Z; Zhu X; Zheng F; Xing Z; Xia Z; He F; Luo J; Tang T; Wang Y
    Comput Struct Biotechnol J; 2021; 19():1002-1013. PubMed ID: 33613866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxy-Safflower Yellow A Mitigates Vascular Remodeling in Rat Pulmonary Arterial Hypertension.
    Ji XY; Lei CJ; Kong S; Li HF; Pan SY; Chen YJ; Zhao FR; Zhu TT
    Drug Des Devel Ther; 2024; 18():475-491. PubMed ID: 38405578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network Pharmacology and Transcriptomics to Explore the Pharmacological Mechanisms of 20(S)-Protopanaxatriol in the Treatment of Depression.
    Guo X; Su L; Shi M; Sun L; Chen W; Geng J; Li J; Zong Y; He Z; Du R
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network Analysis and Experimental Verification of the Mechanisms of Hydroxysafflor Yellow A in Ischemic Stroke Following Atherosclerosis.
    Han X; Zhou H; Yin J; Zhu J; Yang J; Wan H
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of hydroxysafflor yellow A on acute liver injury based on transcriptomics.
    Hou X; Zhang Z; Ma Y; Jin R; Yi B; Yang D; Ma L
    Front Pharmacol; 2022; 13():966759. PubMed ID: 36120318
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanism of Bupleurum scorzonerifolium and Paeonia lactiflora herbal pair against liver cancer: an exploration based on UPLC-Q-TOF-MS combined with network pharmacology].
    Zou X; Sui Y; Tang XY; Zhang R; Shu Q; Gong T; Wu S; Sun ZW; Li WL; Qu ZY
    Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(13):3597-3608. PubMed ID: 35850814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Hydroxysafflor Yellow A on Inflammatory Injury in LPS-induced Endothelial Cell Injury Model through TLR4/NF-κB Pathway Based on Network Pharmacology and Experimental Verification.
    Guo Q; Zhu X; Zhang X; Wang X; Fu F; She W
    Curr Pharm Biotechnol; 2024 Aug; ():. PubMed ID: 39219424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active ingredients and molecular targets of
    Zheng Y; Ji S; Li X; Feng Q
    PeerJ; 2022; 10():e13737. PubMed ID: 35873910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the effect and mechanism of cucurbitacin B on cholestatic liver injury based on network pharmacology and experimental verification.
    Dai S; Wu R; Fu K; Li Y; Yao C; Liu Y; Zhang F; Zhang S; Guo Y; Yao Y; Li Y
    J Ethnopharmacol; 2024 Mar; 322():117584. PubMed ID: 38104874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of the potential mechanism of compound gingerol against liver cancer based on network pharmacology and experimental verification.
    Su M; Wang X; Cao G; Sun L; Ho RJY; Han Y; Hong Y; Wu D
    J Pharm Pharmacol; 2022 Jun; 74(6):869-886. PubMed ID: 35429380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of astragaloside Ⅳ alleviating PC12 cell injury by activating PI3K/AKT signaling pathway: based on network pharmacology and in vitro experiments].
    Zhang TQ; Li CC; Zhang TF; Wang MY; Cui SN; Huo Q
    Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(24):6465-6473. PubMed ID: 34994139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
    Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
    Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of the Molecular Mechanism of Polygonati Rhizoma in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking.
    Zhao J; Lin F; Liang G; Han Y; Xu N; Pan J; Luo M; Yang W; Zeng L
    Front Endocrinol (Lausanne); 2021; 12():815891. PubMed ID: 35069454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of Zicui Decoction in treatment of diabetic kidney disease based on network pharmacology and molecular docking].
    Gao LD; Liu J; Huang YH; Wang BH
    Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3339-3347. PubMed ID: 35851128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discussion on the molecular mechanism of Duhuo Jisheng decoction in treating osteoarthritis based on network pharmacology and molecular docking.
    Yang L; Zheng S; Hou A; Wang S; Zhang J; Yu H; Wang X; Lan W
    Medicine (Baltimore); 2022 Oct; 101(42):e31009. PubMed ID: 36281111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and mechanism of berberine in improving aging-related cognitive dysfunction: A study based on network pharmacology.
    Yao J; Wei W; Wen J; Cao Y; Li H
    Front Neurosci; 2023; 17():1093180. PubMed ID: 36743801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
    Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
    Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.